RX - OTC Switch

Evidence Based Marketing has been widely involved in the launch evaluation, implementation and post launch tracking of a number of major OTC switches in the UK and Europe including:

Zovirax, Lamisil, Voltaren, Eumovate, Beconase, Nicotinell,
Zocor Heart Pro and Zantac.

They have extensive experience both client and consultancy side in this regard and have detailed knowledge of the processes and issues that determine a balanced evaluation of the Rx and OTC implications for any switch.

EBM have developed a specific switch evaluation tool based on extensive case study analysis incorporating a comprehensive list of both successful and unsuccessful switches.